SCHEMBL31731607

SCHEMBL31731607

CCOC(=O)[C@H](Cc1ccc(Oc2ccc(C=O)cc2)cc1)OCC

nearest known ligand 0.51

Predicted protein targets (top 3)

geneUniProtsupporting neighboursconfidence
▸ PPARA Q07869 20/20 0.51
▸ PPARD Q03181 14/20 0.51
▸ PPARG P37231 13/20 0.51

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1869400 0.83 PPARA (0.49) PPARAPPARDPPARG
SCHEMBL5367466 0.81 PPARA (0.49) PPARAPPARDPPARG
SCHEMBL14539076 0.79 PPARA (0.73) PPARAPPARDPPARG
SCHEMBL5380615 0.79 PPARA (0.82) PPARAPPARDPPARG
SCHEMBL7020023 0.78 PPARA (0.62) PPARAPPARDPPARG
SCHEMBL7020019 0.78 PPARA (0.62) PPARAPPARDPPARG
SCHEMBL2554435 0.78 PPARA (0.52) PPARAPPARDPPARG
SCHEMBL7023381 0.78 PPARA (0.76) PPARAPPARDPPARG
SCHEMBL5415596 0.77 PPARA (0.49) PPARAPPARDPPARG
SCHEMBL5415603 0.77 PPARA (0.49) PPARAPPARDPPARG

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-12606533-B2 3-phenylpropylamine derivative DAIICHI SANKYO COMPANY, LIMITED (JP) 2026-04-21 — — US disclosed
US-20250353824-A1 3-PHENYLPROPYLAMINE DERIVATIVE DAIICHI SANKYO COMPANY, LIMITED (JP) 2025-11-20 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20250353824-A1 3-PHENYLPROPYLAMINE DERIVATIVE SF1, SF3A1, SFXN1 PPARA 3088/4885PPARD 2075/4885PPARG 3715/4885
US-12606533-B2 3-phenylpropylamine derivative SF3A1, SF1, HTR1D PPARA 3839/4885PPARD 3022/4885PPARG 3471/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback